318 related articles for article (PubMed ID: 28965585)
1. Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
Hachmöller O; Zibert A; Zischka H; Sperling M; Groba SR; Grünewald I; Wardelmann E; Schmidt HH; Karst U
J Trace Elem Med Biol; 2017 Dec; 44():26-31. PubMed ID: 28965585
[TBL] [Abstract][Full Text] [Related]
2. Investigating the influence of standard staining procedures on the copper distribution and concentration in Wilson's disease liver samples by laser ablation-inductively coupled plasma-mass spectrometry.
Hachmöller O; Aichler M; Schwamborn K; Lutz L; Werner M; Sperling M; Walch A; Karst U
J Trace Elem Med Biol; 2017 Dec; 44():71-75. PubMed ID: 28965603
[TBL] [Abstract][Full Text] [Related]
3. Element bioimaging of liver needle biopsy specimens from patients with Wilson's disease by laser ablation-inductively coupled plasma-mass spectrometry.
Hachmöller O; Aichler M; Schwamborn K; Lutz L; Werner M; Sperling M; Walch A; Karst U
J Trace Elem Med Biol; 2016 May; 35():97-102. PubMed ID: 27049132
[TBL] [Abstract][Full Text] [Related]
4. High spatial resolution LA-ICP-MS demonstrates massive liver copper depletion in Wilson disease rats upon Methanobactin treatment.
Müller JC; Lichtmannegger J; Zischka H; Sperling M; Karst U
J Trace Elem Med Biol; 2018 Sep; 49():119-127. PubMed ID: 29895360
[TBL] [Abstract][Full Text] [Related]
5. D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease.
Członkowska A; Litwin T; Karliński M; Dziezyc K; Chabik G; Czerska M
Eur J Neurol; 2014 Apr; 21(4):599-606. PubMed ID: 24447648
[TBL] [Abstract][Full Text] [Related]
6. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
[TBL] [Abstract][Full Text] [Related]
7. Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease.
Zhang J; Xiao L; Yang W
BMC Neurol; 2020 Jun; 20(1):255. PubMed ID: 32593295
[TBL] [Abstract][Full Text] [Related]
8. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
McQuaid A; Lamand M; Mason J
J Lab Clin Med; 1992 Jun; 119(6):744-50. PubMed ID: 1593220
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study].
Li M; Zhang YH; Qin J
Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):119-22. PubMed ID: 14759316
[TBL] [Abstract][Full Text] [Related]
10. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
11. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
Dzieżyc K; Karliński M; Litwin T; Członkowska A
Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
[TBL] [Abstract][Full Text] [Related]
12. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Walshe JM
QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
[TBL] [Abstract][Full Text] [Related]
13. Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators.
Delangle P; Mintz E
Dalton Trans; 2012 Jun; 41(21):6359-70. PubMed ID: 22327203
[TBL] [Abstract][Full Text] [Related]
14. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.
Dzieżyc K; Litwin T; Chabik G; Członkowska A
Funct Neurol; 2015; 30(4):264-8. PubMed ID: 26727705
[TBL] [Abstract][Full Text] [Related]
15. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Lange J; Brandt G
Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
[No Abstract] [Full Text] [Related]
16. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
17. μXRF and LA-ICP-TQMS for quantitative bioimaging of iron in organ samples of a hemochromatosis model.
Müller JC; Horstmann M; Traeger L; Steinbicker AU; Sperling M; Karst U
J Trace Elem Med Biol; 2019 Mar; 52():166-175. PubMed ID: 30732878
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
[TBL] [Abstract][Full Text] [Related]
19. Iron accumulation in the liver of male patients with Wilson's disease.
Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
[TBL] [Abstract][Full Text] [Related]
20. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
